Provided by Tiger Trade Technology Pte. Ltd.

NRX Pharmaceuticals Inc.

2.91
+0.05501.93%
Post-market: 2.940.0350+1.20%19:55 EDT
Volume:613.07K
Turnover:1.77M
Market Cap:125.77M
PE:-3.75
High:2.94
Open:2.91
Low:2.82
Close:2.85
52wk High:5.06
52wk Low:1.62
Shares:43.30M
Float Shares:37.42M
Volume Ratio:0.80
T/O Rate:1.64%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.7754
EPS(LYR):-1.3374
ROE:-682.61%
ROA:-63.99%
PB:-739.85
PE(LYR):-2.17

Loading ...

NRX Pharmaceuticals is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Oct 01

NRx Defense Systems, NRX Pharma Unit, Wins $11.18 Million DARPA Contract for Depression Treatment Trial

Reuters
·
Sep 30

NRX Defense Systems, an NRX Company (Nasdaq:Nrxp) Awarded $11 Million Dollar Darpa Prime Contract to Evaluate Robotic Magnetic Stimulation in Conjunction with NRX-101 for Treatment of Resistant Depression

THOMSON REUTERS
·
Sep 30

NRX Pharmaceuticals (NRXP) Receives a Rating Update from a Top Analyst

TIPRANKS
·
Sep 22

NRx Pharma Says FDA Reclassifies Ketamine ANDA Amendment as Minor, Sets Nov. 10, 2026 Goal Date

Reuters
·
Sep 16

NRx Pharmaceuticals says FDA reclassifies ANDA amendment to ‘minor’

TIPRANKS
·
Sep 16

NRX Pharmaceuticals - FDA Revises Gdufa Goal Date for Anda Amendment to November 10, 2026

THOMSON REUTERS
·
Sep 16

NRx Pharmaceuticals (Nasdaq: NRXP) Reports Update from the FDA Revising Previous Major Amendment to a Minor Amendment for Preservative-free Ketamine

GlobeNewswire
·
Sep 16

NRX Pharmaceuticals Price Target Maintained with a $10.00/Share by BTIG

Dow Jones
·
Sep 15

NRx Pharma Unit GeNeuro Wins European Patent for ALS Antibody Candidate GNK-301

Reuters
·
Sep 14

NRX Pharmaceuticals' HOPE Therapeutics to Deploy Zeta's TMS Robotic System

MT Newswires Live
·
Sep 11

NRx Pharma to Present at Moody Capital Solutions Disruptive Growth & Life Sciences Conference

Reuters
·
Sep 08

NRX Pharmaceuticals Price Target Maintained with a $45.00/Share by HC Wainwright & Co.

Dow Jones
·
Aug 26

NRX Pharmaceuticals Price Target Maintained with a $10.00/Share by BTIG

Dow Jones
·
Aug 18

NRX Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 17

NRX Pharmaceuticals Q2 EPS $(0.44) Misses $0.06 Estimate, Sales $1.101M Miss $17.488M Estimate

Benzinga Earnings
·
Aug 17

NRX Pharmaceuticals (Nasdaq:Nrxp) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17TH at 4:30Pm Et

THOMSON REUTERS
·
Aug 17

NRX Pharmaceuticals - Reports Cash and Cash Equivalents of $26.70 Mln as of June 30, 2026

THOMSON REUTERS
·
Aug 17

Press Release: NRx Pharmaceuticals (Nasdaq:NRXP) Reports Second Quarter 2026 Financial Results and Provides Corporate Update; Conference Call to be Held on Monday, August 17th at 4:30pm ET

Dow Jones
·
Aug 17

NRx Pharma Q2 FY26 Net Loss Narrows to $16.52 Million; Revenue Rises to $1.1 Million

Reuters
·
Aug 15